John Newell-Price, MD, PhD, FRCP, professor of endocrinology at the University of Sheffield, honorary consultant physician at Sheffield Teaching Hospitals NHS Foundation Trust, and past-president of the Endocrine Society, has been appointed as the new Clinical Research Director at Sheffield Teaching Hospitals NHS Foundation Trust.
Newell-Price’s clinical expertise includes pituitary and adrenal disorders, genetic endocrine disease, and neuroendocrine tumors and cancer. His research group focuses on glucocorticoid excess and deficiency, with discoveries that have resulted in new paradigms of diagnosis and treatment.
Together with colleagues, Newell-Price has developed Sheffield into a world-leading patient-centered clinical endocrine service where clinical and translational research and innovation is embedded, being funded by UK Research and Innovation (UKRI), industry and charities.
He has led nationally with NHS England and the Royal College of Physicians to set standards of care in his field, and internationally on numerous evidence-based clinical practice guidelines. In addition to his extensive leadership, Newell-Price has a longstanding commitment to developing, championing and training medical students and researchers in the early stages of their careers, as well as a long track-record of working closely with patient groups.
“I am honored to take on the role of clinical research director at Sheffield Teaching Hospitals NHS Foundation Trust. Our research and innovation, led by our senior research and innovation leadership and talented CRIO team, is built on a foundation of clinically excellent collaboration and innovation.” – John Newell-Price, MD, PhD, FRCP, on his new position with Sheffield Teaching Hospitals NHS Foundation Trust
Newell-Price will be part of the team that drives forward the Trust’s new research and innovation strategy which also supports the 10 Year Health Plan for England, aiming to create a future-ready NHS using new technologies, medicines, and innovations to support prevention and treatment of clinical conditions. He will also be responsible for co-leading the Clinical Research and Innovation Office (CRIO).
“I am honored to take on the role of clinical research director at Sheffield Teaching Hospitals NHS Foundation Trust,” Newell-Price says. “Our research and innovation, led by our senior research and innovation leadership and talented CRIO team, is built on a foundation of clinically excellent collaboration and innovation.”
Newell-Price succeeds Simon Heller, MD, professor of clinical diabetes at the University of Sheffield, who served in that position for 19 years. “I am indebted to him for his invaluable leadership and the significant strides he has made in advancing clinical research and innovation at Sheffield Teaching Hospitals.”
“I look forward to working with everyone including patients, staff, public, industry, universities, charities and stakeholders to ensure our research and innovation continues to make a real difference to patients’ lives in the region and beyond,” Newell-Price says.
Loading ...